S-infinity Pharmaceuticals Co., Ltd

This study tested a new drug called XH-S003 in 25 adults with IgA nephropathy, a kidney disease. The goal was to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage, after 90 days. Participants had to have a kidney biopsy confirming the disease. T…

Researchers are running a phase 1 trial of XH-S004, an experimental oral tablet, in healthy adults aged 18 to 45. The study gives single and multiple rising doses, plus doses with food, to see how the body handles the drug and whether it causes side effects. Participants receive …